Are you Dr. Kelmendi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 38 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 George St Ste 901
New Haven, CT 06511Phone+1 203-785-2095- Is this information wrong?
Summary
- Dr. Benjamin Kelmendi, MD is a board certified psychiatrist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut.
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 2011 - 2015
University of Vermont College of MedicineClass of 2011
Certifications & Licensure
CT State Medical License 2013 - 2025- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. Start of enrollment: 2024 Jan 01
Publications & Presentations
PubMed
- 3 citationsMisinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.O'Donnell, K., Barrett, F., Bogenschutz, M., Hendricks, P., Nicholas, C., Anderson, B., Grob, C., Kelmendi, B., Nayak, S., Paleos, C., Stauffer, C., Gukasyan, N.> ;The American Journal of Psychiatry. 2024 Jan 1
- Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-co...Ching, T., Amoroso, L., Bohner, C., D'Amico, E., Eilbott, J., Entezar, T., Fitzpatrick, M., Fram, G., Grazioplene, R., Hokanson, J., Jankovsky, A., Kichuk, S., Martins...> ;Frontiers in Psychiatry. 2024 Jan 1
- Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA.Warner-Schmidt, J., Stogniew, M., Mandell, B., Rowland, R., Schmidt, E., Kelmendi, B.> ;Frontiers in Neuroscience. 2024 Jan 1
- Join now to see all
Authored Content
- Developing Image Sets for Inducing Obsessive-Compulsive Checking SymptomsApril 2018
- Developing Image Sets for Inducing Obsessive-Compulsive Checking SymptomsApril 2018
Press Mentions
Changing Lives with Psychedelics: How Connecticut Researchers Are Using Magic Mushrooms to Help People Overcome Depression, OCDNovember 17th, 2022- NIH: It’s Time to Make Your Mark on the Renaissance of Medicinal PsychedelicsJune 2nd, 2021
- Global Psychedelic Therapeutics Market Is Projected to Grow at an Annualized Rate of ~15%, Till 2030January 12th, 2021
